Healthcare -
Biotechnology - NASDAQ - US
$ 40.61
0.794 %
$ 2.63 B
Market Cap
-17.35
P/E
KYMR - NET INCOME
Net Income KYMR - Kymera Therapeutics, Inc.
-147 M
LAST VALUE
-21.10%
2 YEAR CAGR
-46.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR